Status |
Operational, Accepting Proposals |
Source |
Bending Magnet |
Energy Range |
15 – 40 keV |
Wavelength |
1.6
– 0.3 Å |
Resolution Δ E / E @ E |
M1 DCM 0.57 x 10-4 with Si(2,2,0) |
Photon Brightness |
1.5 x 10¹¹ ph (s * mr² * 0.1%bW * mA) @ 10 keV |
| Beam Size (Horizontal x Vertical) |
240 mm x 7 mm @ 23 m |
Description: The BioMedical Imaging and Therapy (BMIT) beamline is designed for the purpose of imaging biological tissue and conducting radiation therapy research. The BMIT facility will address the interest of scientists and clinicians in the diagnosis and treatment of cancer (breast tumours and paediatric oncology), circulatory and respiratory disease (heart disease and asthma) neurological and behavioural disease (brain and spinal cord injuries, epilepsy), reproductive dysfunction (infertility, menopause, and contraceptives), musculo-skeletal disease and kinesiology (arthritis, athletic injuries), and dental conditions (temporomandibular disorder).
Endstation(s):
- Custom positioning system. Max. load capacity 50 kg.
Techniques:
- Conventional absorption imaging
- Diffraction Enhanced Imaging (DEI) / Multiple Image Radiography (MIR)
- Phase contrast or in-line holography
- Ultra-small, small, wide angle scattering imaging
- Computer Tomography (CT)
Optics:
Technical beamline one-pager (PDF)
|
Left to right: David Cooper, Jeffrey To, Denise Miller, Dean Chapman (above), Adam Webb, Stephen Hanson; In front: Tomasz Wysokinski, George Belev
|
